147
Views
17
CrossRef citations to date
0
Altmetric
One Year Exposure of Rats to Electromagnetic Fields

One-year, simultaneous combined exposure of CDMA and WCDMA radiofrequency electromagnetic fields to rats

, , , , &
Pages 416-423 | Received 26 Jan 2010, Accepted 24 Oct 2010, Published online: 21 Dec 2010

References

  • Anderson LE, Sheen DM, Wilson BW, Grumbein SL, Creim JA, Sasser LB. 2004. Two-year chronic bioassay study of rats exposed to a 1.6 GHz radiofrequency signal. Radiation Research 162:201–210.
  • Cameron TP, Hickmann RL, Kornreich MR, Tarone RE. 1985. History, survival, and growth patterns of B6C3F1 mice and F344 rats in the National Cancer Institute Carcinogenesis Testing Program. Fundamental and Applied Toxicology 5:526–538.
  • Chandra M, Riley MG, Johnson DE. 1992. Spontaneous neoplasms in aged Sprague-Dawley rats. Archives of Toxicology 66:496–502.
  • Chin BH, Tyler TR, Kozbelt SH. 1979. The interfering effects of hemolyzed blood on rat serum chemistry. Toxicological Pathology 7:19–22.
  • Hagadorn JE, Bloor CM, Yang MS. 1971. Elevated plasma activity of lactate dehydrogenase isoenzyme-3 (LDH3) in experimentally-induced immunologic lung injury. American Journal of Pathology 64:575–584.
  • Haseman JK, Hailey JR, Morris RW. 1998. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: A National Toxicology Program update. Toxicologic Pathology 26:428–441.
  • Hoffman RM, Rogers RM. 1991. Serum and lavage lactate dehydrogenase isoenzymes in pulmonary alveolar proteinosis. American Review of Respiratory Disease Journal 143:42–46.
  • Lee HJ, Lee JS, Pack JK, Choi HD, Kim N, Kim SH, Lee YS. 2009. Lack of teratogenicity after combined exposure of pregnant mice to CDMA and WCDMA radiofrequency electromagnetic fields. Radiation Research 172:648–652.
  • Matusiewicz SP, Williamson IJ, Sime PJ, Brown PH, Wenham PR, Crompton GK, Greening AP. 1993. Plasma lactate dehydrogenase: A marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis? European Respiratory Journal 6:1282–1286.
  • Oberto G, Rolfo K, Yu P, Carbonatto M, Peano S, Kuster N, Ebert S, Tofani S. 2007. Carcinogenicity study of 217 Hz pulsed 900 MHz electromagnetic fields in Pim1 transgenic mice. Radiation Research 168:316–326.
  • Prejean JD, Peckham JC, Casey AE, Griswold DP, Weisburger EK, Weisburger JH. 1973. Spontaneous tumors in Sprague-Dawley rats and Swiss mice. Cancer Research 33:2768–2773.
  • Regina ML, Moros EG, Pickard WF, Straube WL, Baty J, Roti RL. 2003. The effect of chronic exposure to 835.62 MHz FDMA or 847.74 MHz CDMA radiofrequency radiation on the incidence of spontaneous tumors in rats. Radiation Research 160:143–151.
  • Smith P, Kuster N, Ebert S, Chevalier HJ. 2007. GSM and DCS wireless communication signals: Combined chronic toxicity/carcinogenicity study in the Wistar rat. Radiation Research 168:480–492.
  • Tillmann T, Ernst H, Ebert S, Kuster N, Behnke W, Rittinghausen S, Dasenbrock C. 2007. Carcinogenicity study of GSM and DCS wireless communication signals in B6C3F1 mice. Bioelectromagnetics 28:173–187.
  • Ziemann C, Brockmeyer H, Reddy SB, Vijayalaxmi, Prihoda TJ, Kuster N, Tillmann T, Dasenbrock C. 2009. Absence of genotoxic potential of 902 MHz (GSM) and 1747 MHz (DCS) wireless communication signals: In vivo two-year bioassay in B6C3F1 mice. International Journal of Radiation Biology 85:454–464.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.